Viewing Study NCT01573533


Ignite Creation Date: 2025-12-25 @ 2:40 AM
Ignite Modification Date: 2026-03-01 @ 8:55 PM
Study NCT ID: NCT01573533
Status: COMPLETED
Last Update Posted: 2020-02-10
First Post: 2012-04-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS
Sponsor: Mayo Clinic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Focal Segmental Glomerulosclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Treatment Resistant Idiopathic FSGS View
None Glomerulosclerosis View
None Proteinuria View
None Rituximab View